Diane Tseng - Publications

Affiliations: 
Stanford University, Palo Alto, CA 

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Tokaz MC, Baik CS, Houghton AM, Tseng D. New Immuno-oncology Targets and Resistance Mechanisms. Current Treatment Options in Oncology. 23: 1201-1218. PMID 35980521 DOI: 10.1007/s11864-022-01005-8  0.307
2021 Chiou SH, Tseng D, Reuben A, Mallajosyula V, Molina IS, Conley S, Wilhelmy J, McSween AM, Yang X, Nishimiya D, Sinha R, Nabet BY, Wang C, Shrager JB, Berry MF, et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 54: 586-602.e8. PMID 33691136 DOI: 10.1016/j.immuni.2021.02.014  0.511
2020 Nabet BY, Esfahani MS, Moding EJ, Hamilton EG, Chabon JJ, Rizvi H, Steen CB, Chaudhuri AA, Liu CL, Hui AB, Almanza D, Stehr H, Gojenola L, Bonilla RF, Jin MC, ... ... Tseng D, et al. Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition. Cell. PMID 33007267 DOI: 10.1016/j.cell.2020.09.001  0.352
2020 Nabet BY, Esfahani MS, Hamilton EG, Chabon JJ, Moding EJ, Rizvi H, Steen CB, Chaudhuri AA, Liu CL, Hui AB, Stehr H, Goljenola L, Jin MC, Jeon Y, Tseng D, et al. Abstract 5666: A noninvasive approach for early prediction of therapeutic benefit from immune checkpoint inhibition for lung cancer Tumor Biology. DOI: 10.1158/1538-7445.Am2020-5666  0.318
2013 Tseng D, Volkmer JP, Willingham SB, Contreras-Trujillo H, Fathman JW, Fernhoff NB, Seita J, Inlay MA, Weiskopf K, Miyanishi M, Weissman IL. Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response. Proceedings of the National Academy of Sciences of the United States of America. 110: 11103-8. PMID 23690610 DOI: 10.1073/Pnas.1305569110  0.563
2012 Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, ... ... Tseng D, et al. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proceedings of the National Academy of Sciences of the United States of America. 109: 6662-7. PMID 22451913 DOI: 10.1073/Pnas.1121623109  0.63
2011 Tseng D, Vasquez-Medrano DA, Brown JM. Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas. British Journal of Cancer. 104: 1805-9. PMID 21587260 DOI: 10.1038/Bjc.2011.169  0.304
2010 Ahn GO, Tseng D, Liao CH, Dorie MJ, Czechowicz A, Brown JM. Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proceedings of the National Academy of Sciences of the United States of America. 107: 8363-8. PMID 20404138 DOI: 10.1073/Pnas.0911378107  0.759
2009 Park CY, Tseng D, Weissman IL. Cancer stem cell-directed therapies: Recent data from the laboratory and clinic Molecular Therapy. 17: 219-230. PMID 19066601 DOI: 10.1038/Mt.2008.254  0.634
2007 Dutt S, Tseng D, Ermann J, George TI, Liu YP, Davis CR, Fathman CG, Strober S. Naive and memory T cells induce different types of graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 179: 6547-54. PMID 17982043 DOI: 10.4049/Jimmunol.179.10.6547  0.476
2007 Park CY, Wang Y, Prohaska S, Tseng D, Weissman IL. MicroRNA Profiling of Human Acute Myeloid Leukemia and Normal Hematopoietic Stem/Progenitor Cells Reveals a Leukemia Stem Cell Signature. Blood. 110: 779-779. DOI: 10.1182/Blood.V110.11.779.779  0.557
2006 Dutt S, Tseng D, George TI, Ermann J, Liu Y, Fathman CG, Strober S. Allosensitized Memory CD4 T Cells Induce Chronic Graft Versus Host Disease. Blood. 108: 449-449. DOI: 10.1182/Blood.V108.11.449.449  0.543
2005 Dutt S, Ermann J, Tseng D, Liu YP, George TI, Fathman CG, Strober S. L-selectin and beta7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease. Blood. 106: 4009-15. PMID 16105972 DOI: 10.1182/Blood-2005-06-2339  0.479
2005 Dutt S, Tseng D, Ermann J, Liu YP, George TI, Fathman CG, Strober S. Memory CD4 T Cells Induce Graft Versus Host Disease. Blood. 106: 1309-1309. DOI: 10.1182/Blood.V106.11.1309.1309  0.566
Show low-probability matches.